Literature DB >> 6788166

Haemolytic anaemia after cisplatin treatment.

J A Levi, R S Aroney, D N Dalley.   

Abstract

Normochromic or normocytic anaemia is a common side effect of treatment with cisplatin. Two patients treated with cisplatin 100 mg/m2 in combination with vinblastine, bleomycin, and actinomycin D developed haemolytic anaemia. Neither patient had evidence of haemolysis before treatment, and in both cases severe haemolytic anaemia developed after several courses of cisplatin and when the cancer had regressed almost completely. The importance of haemolysis in the development of anaemia after cisplatin treatment has not been investigated fully and further studies are needed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788166      PMCID: PMC1505958          DOI: 10.1136/bmj.282.6281.2003

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  5 in total

Review 1.  Cis-platinum: a new anticancer agent.

Authors:  C J Williams; J M Whitehouse
Journal:  Br Med J       Date:  1979-06-23

Review 2.  Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Authors:  D D Von Hoff; R Schilsky; C M Reichert; R L Reddick; M Rozencweig; R C Young; F M Muggia
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

3.  Cisplatin toxicity for erythroid precursors.

Authors:  S A Rothmann; J K Weick
Journal:  N Engl J Med       Date:  1981-02-05       Impact factor: 91.245

4.  Cisplatin-induced hemolysis.

Authors:  E P Getaz; S Beckley; J Fitzpatrick; A Dozier
Journal:  N Engl J Med       Date:  1980-02-07       Impact factor: 91.245

5.  Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.

Authors:  C L Litterst; A F LeRoy; A M Guarino
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct
  5 in total
  11 in total

1.  Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin.

Authors:  G Cinollo; G Dini; E Franchini; E Lanino; F Sindaco; A Garaventa
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 2.  Hypersensitivity and cross-reactivity to cisplatin and analogues.

Authors:  A A Shlebak; P I Clark; J A Green
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

3.  Adverse effect of cis-diamminedichloroplatinum II (CDDP) on porphyrin metabolism in man.

Authors:  C G Alexopoulos; G Chalevelakis; C Katsoulis; G Pallikaris
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.

Authors:  A Johnsson; C Olsson; O Nygren; M Nilsson; B Seiving; E Cavallin-Stahl
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway.

Authors:  Haizhi Huang; Allen Y Chen; Xingqian Ye; Bingyun Li; Yon Rojanasakul; Gary O Rankin; Yi Charlie Chen
Journal:  Int J Oncol       Date:  2015-08-25       Impact factor: 5.650

6.  Bactericidal activity of alpha-bromocinnamaldehyde against persisters in Escherichia coli.

Authors:  Qingshan Shen; Wei Zhou; Liangbin Hu; Yonghua Qi; Hongmei Ning; Jian Chen; Haizhen Mo
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

7.  In vitro cytotoxicity activity of novel Schiff base ligand-lanthanide complexes.

Authors:  Kavitha Andiappan; Anandhavelu Sanmugam; Easwaramoorthy Deivanayagam; K Karuppasamy; Hyun-Seok Kim; Dhanasekaran Vikraman
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

8.  Effects of cisplatin on different haemopoietic progenitor cells in mice.

Authors:  M R Nowrousian; C G Schmidt
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

9.  Nonpreventive Role of Aerobic Exercise Against Cisplatin-induced Nephrotoxicity in Female Rats.

Authors:  Jalaledin Noroozi; Farzaneh Zeynali; Mehdi Nematbakhsh; Zahra Pezeshki; Ardeshir Talebi
Journal:  Int J Prev Med       Date:  2015-07-08

10.  Benzene-poly-carboxylic acid complex, a novel anti-cancer agent induces apoptosis in human breast cancer cells.

Authors:  Fuad Fares; Naiel Azzam; Basem Fares; Stig Larsen; Steen Lindkaer-Jensen
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.